www.fdanews.com/articles/176208-fda-clears-next-gen-enroute-transcarotid-neuroprotection-system
FDA Clears Next-Gen Enroute Transcarotid Neuroprotection System
April 14, 2016
Silk Road Medical has gained FDA clearance for its next-generation Enroute transcarotid neuroprotection system, indicated for transcarotid artery revascularization.
The system allows for direct access to the carotid artery to target blockages that could cause a stroke.
The first procedures with the device have been performed across the country. — Anisa Jibrell